Patents by Inventor Gabriel Nussbaum

Gabriel Nussbaum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210393711
    Abstract: The present invention provides transgenic bacteria capable of secreting single chain antibodies and antibody fragments directed to Toll-Like Receptors. Compositions comprising the transgenic bacteria and method of preventing and treating infectious, inflammatory and proliferative conditions are also provided.
    Type: Application
    Filed: October 10, 2019
    Publication date: December 23, 2021
    Inventors: Gabriel NUSSBAUM, Carsten KIRSHNING
  • Patent number: 10662225
    Abstract: Provided are backbone cyclized peptides that interfere with signaling of the intracellular adaptor protein MyD88. Pharmaceutical compositions including these backbone cyclized peptides as well as their use in treatment of multiple sclerosis (MS) and other diseases associated with MyD88 signaling are also disclosed.
    Type: Grant
    Filed: June 4, 2017
    Date of Patent: May 26, 2020
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Gabriel Nussbaum, Amnon Hoffman, Chaim Gilon
  • Publication number: 20190185516
    Abstract: Provided are backbone cyclized peptides that interfere with signaling of the intracellular adaptor protein MyD88. Pharmaceutical compositions including these backbone cyclized peptides as well as their use in treatment of multiple sclerosis (MS) and other diseases associated with MyD88 signaling are also disclosed.
    Type: Application
    Filed: June 4, 2017
    Publication date: June 20, 2019
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Gabriel NUSSBAUM, Amnon HOFFMAN, Chaim GILON
  • Patent number: 9314491
    Abstract: Provided, among other things, is a method of treating or ameliorating an indication of non-mucosal topical tissue comprising periodically applying to such disease affected tissue a composition comprising: an effective amount of an appropriate composition of herbal bioactive comprising active(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea, and an effective amount of a quaternary ammonium surfactant.
    Type: Grant
    Filed: October 10, 2013
    Date of Patent: April 19, 2016
    Assignee: Izun Pharmaceuticals, Inc.
    Inventors: William Zev Levine, Aron Jay Saffer, Gabriel Nussbaum
  • Patent number: 8771759
    Abstract: Provided, among other things, is a method of treating or ameliorating an indication of non-mucosal topical tissue comprising periodically applying to such disease affected tissue a composition comprising: an effective amount of an appropriate composition of herbal bioactive comprising active(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea, and an effective amount of a quaternary ammonium surfactant.
    Type: Grant
    Filed: July 15, 2009
    Date of Patent: July 8, 2014
    Assignee: Izun Pharmaceuticals, Inc.
    Inventors: William Zev Levine, Aron Jay Saffer, Gabriel Nussbaum
  • Publication number: 20140099389
    Abstract: Provided, among other things, is a method of treating or ameliorating an indication of non-mucosal topical tissue comprising periodically applying to such disease affected tissue a composition comprising: an effective amount of an appropriate composition of herbal bioactive comprising active(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea, and an effective amount of a quaternary ammonium surfactant.
    Type: Application
    Filed: October 10, 2013
    Publication date: April 10, 2014
    Applicant: IZUN PHARMACEUTICALS, INC.
    Inventors: William Zev Levine, Aron Jay Saffer, Gabriel Nussbaum
  • Patent number: 8414899
    Abstract: The present invention provides improved vaccine compositions having enhanced immunogenicity and methods of using same. The compositions and methods include immunogenic conjugates containing peptide carriers derived from heat shock protein 60 (HSP60). The known synthetic peptide carrier, p458, provides significantly improved immunogenicity when provided as a multimeric conjugate comprising a plurality of peptide carrier units conjugated to each antigen. Cell vaccine compositions comprising antigen presenting cells loaded with multimeric p458 conjugates are also provided.
    Type: Grant
    Filed: April 11, 2007
    Date of Patent: April 9, 2013
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Irun R. Cohen, Hila Amir-Kroll, Noam Cohen, Gabriel Nussbaum
  • Publication number: 20110151032
    Abstract: Provided, among other things, is a method of treating or ameliorating an indication of non-mucosal topical tissue comprising periodically applying to such disease affected tissue a composition comprising: an effective amount of an appropriate composition of herbal bioactive comprising active(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea, and an effective amount of a quaternary ammonium surfactant.
    Type: Application
    Filed: July 15, 2009
    Publication date: June 23, 2011
    Inventors: William Zev Levine, Gabriel Nussbaum
  • Publication number: 20090269370
    Abstract: The present invention provides improved vaccine compositions having enhanced immunogenicity and methods of using same. The compositions and methods include immunogenic conjugates containing peptide carriers derived from heat shock protein 60 (HSP60). The known synthetic peptide carrier, p458, provides significantly improved immunogenicity when provided as a multimeric conjugate comprising a plurality of peptide carrier units conjugated to each antigen. Cell vaccine compositions comprising antigen presenting cells loaded with multimeric p458 conjugates are also provided.
    Type: Application
    Filed: April 11, 2007
    Publication date: October 29, 2009
    Applicant: YEDA Research and Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Irun R. Cohen, Hila Amir-Kroll, Noam Cohen, Gabriel Nussbaum